Sponsored Content
Sponsored
The emergence of hospital- and community-based MRSA and other resistant gram-positive pathogens have made ABSSSI a critical public health challenge.
As current antibiotics become less effective due to bacterial resistance, there is high demand for new and effective therapies with both IV and oral formulations.
Trending on Contagion Live
1
Insights Around Incidence Rates and Evolving Diagnostics for Vector-Borne Diseases
2
Early Genomic Surveillance Leads to a Decrease in Candida Auris Cases
3
Who Will Get Tested in the Next Pandemic?
4
Increased RSV Testing Reduced Antibiotic Prescribing for Pediatric Outpatients
5